Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis

NCT00959036 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

252

Enrollment

INDUSTRY

Sponsor class

Conditions

Active Rheumatoid Arthritis

Interventions

DRUG: ATN-103
DRUG: ATN-103
DRUG: ATN-103
DRUG: ATN-103
DRUG: ATN-103
DRUG: Placebo
DRUG: Methotrexate

Sponsor

Ablynx, a Sanofi company